263 related articles for article (PubMed ID: 25963701)
41. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
[TBL] [Abstract][Full Text] [Related]
42. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
Lee J; Lee KE; Im YH; Kang WK; Park K; Kim K; Shim YM
Ann Thorac Surg; 2005 Oct; 80(4):1170-5. PubMed ID: 16181835
[TBL] [Abstract][Full Text] [Related]
44. [Epidermoid cancer of the esophagus: role of radiotherapy and chemotherapy].
Delouche D; Haefliger JM
Rev Med Suisse Romande; 1998 Mar; 118(3):227-34. PubMed ID: 9594596
[No Abstract] [Full Text] [Related]
45. Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus.
Yano M; Yasuda T; Miyata H; Fujiwara Y; Takiguchi S; Monden M
J Surg Oncol; 2005 Mar; 89(4):244-50; discussion 250. PubMed ID: 15726612
[TBL] [Abstract][Full Text] [Related]
46. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
Kim DW; Blanke CD; Wu H; Shyr Y; Berlin J; Beauchamp RD; Chakravarthy B
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):397-404. PubMed ID: 17097833
[TBL] [Abstract][Full Text] [Related]
47. Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?
Ruol A; Rizzetto C; Castoro C; Cagol M; Alfieri R; Zanchettin G; Cavallin F; Michieletto S; Da Dalt G; Sileni VC; Corti L; Mantoan S; Zaninotto G; Ancona E
Ann Surg; 2010 Nov; 252(5):788-96. PubMed ID: 21037434
[TBL] [Abstract][Full Text] [Related]
48. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
49. [A Case of Early Recurrence after Esophagectomy for Cancer Following Neoadjuvant Chemotherapy Resulting in a Complete Response of the Primary Lesion].
Saito H; Nabeya Y; Takiguchi N; Ikeda A; Kainuma O; Soda H; Tonooka T; Arimitsu H; Yanagibashi H; Kobayashi R; Chibana T; Ishige F; Yamamoto H; Hironaka S; Nagata M
Gan To Kagaku Ryoho; 2015 Sep; 42(9):1099-101. PubMed ID: 26469168
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of the second cycle response to cisplatin-based chemotherapy as preoperative treatment for esophageal squamous cell carcinoma.
Akita H; Doki Y; Miyata H; Hirao T; Yano M; Takachi K; Miyashiro I; Sasaki Y; Ishikawa O; Ohigashi H; Imaoka S
J Surg Oncol; 2006 Apr; 93(5):401-9. PubMed ID: 16550577
[TBL] [Abstract][Full Text] [Related]
51. [A resected case of thoracic esophageal cancer in which pCR was obtained using low-dose of nedaplatin (CDGP)/5-FU and radiotherapy].
Takemura M; Osugi H; Lee S; Kaneko M; Tanaka Y; Fujiwara Y; Nishizawa S; Iwasaki H; Higashino M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1399-402. PubMed ID: 15446565
[TBL] [Abstract][Full Text] [Related]
52. [The value of postoperative arterial infusion chemotherapy in patients with T3 esophageal squamous carcinoma after radical surgery].
Liu BD; Zhi XY; Xu QS
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):586-9. PubMed ID: 15949351
[TBL] [Abstract][Full Text] [Related]
53. Phase II study of docetaxel and cisplatin chemotherapy in 5-fluorouracil/cisplatin pretreated esophageal cancer.
Shim HJ; Cho SH; Hwang JE; Bae WK; Song SY; Cho SB; Lee WS; Joo YE; Na KJ; Chung IJ
Am J Clin Oncol; 2010 Dec; 33(6):624-8. PubMed ID: 20142726
[TBL] [Abstract][Full Text] [Related]
54. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204.
Ando N; Iizuka T; Ide H; Ishida K; Shinoda M; Nishimaki T; Takiyama W; Watanabe H; Isono K; Aoyama N; Makuuchi H; Tanaka O; Yamana H; Ikeuchi S; Kabuto T; Nagai K; Shimada Y; Kinjo Y; Fukuda H;
J Clin Oncol; 2003 Dec; 21(24):4592-6. PubMed ID: 14673047
[TBL] [Abstract][Full Text] [Related]
55. The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma.
Tsuchikawa T; Miyamoto M; Yamamura Y; Shichinohe T; Hirano S; Kondo S
Ann Surg Oncol; 2012 May; 19(5):1713-9. PubMed ID: 21822560
[TBL] [Abstract][Full Text] [Related]
56. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
57. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
[TBL] [Abstract][Full Text] [Related]
58. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
59. [A case of pathologic complete response of primary esophageal carcinoma treated with 5-FU/CDDP as neoadjuvant chemotherapy].
Suzuki S; Kaji S; Koike N; Harada N; Tanaka S; Hayashi T; Suzuki M; Hanyu F
Gan To Kagaku Ryoho; 2009 May; 36(5):839-41. PubMed ID: 19461190
[TBL] [Abstract][Full Text] [Related]
60. [Pathological complete response in 2 patients with cT4 esophageal cancer treated with neoadjuvant chemoradiation therapy].
Takagawa R; Mogaki M; Endo C; Kubo H; Nakayama G; Goto A; Homma Y; Minami Y; Watanabe J; Morita T; Masui H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2149-51. PubMed ID: 24394042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
